Format

Send to

Choose Destination
Indian Pacing Electrophysiol J. 2012 Mar;12(2):54-64. Epub 2012 Apr 30.

A case for pharmacogenomics in management of cardiac arrhythmias.

Author information

1
Department of Biotechnology, Delhi Technological University, Shahbad Daulatpur, Main Bawana Road, Delhi, India.

Abstract

Disorders of the cardiac rhythm are quite prevalent in clinical practice. Though the variability in drug response between individuals has been extensively studied, this information has not been widely used in clinical practice. Rapid advances in the field of pharmacogenomics have provided us with crucial insights on inter-individual genetic variability and its impact on drug metabolism and action. Technologies for faster and cheaper genetic testing and even personal genome sequencing would enable clinicians to optimize prescription based on the genetic makeup of the individual, which would open up new avenues in the area of personalized medicine. We have systematically looked at literature evidence on pharmacogenomics markers for anti-arrhythmic agents from the OpenPGx consortium collection and reason the applicability of genetics in the management of arrhythmia. We also discuss potential issues that need to be resolved before personalized pharmacogenomics becomes a reality in regular clinical practice.

KEYWORDS:

Adverse drug reactions; Arrhythmia; Genetic testing; Personal genome; Pharmacogenomics

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center